Clinical Trial Update: Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating palliative radiofrequency ablation for metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Carcinoma, Renal Cell | Phase 1, Phase 2 | Status: COMPLETED